Globus Medical (GMED) EBT Growth (1y) (2012 - 2026)
Globus Medical (GMED) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.94% |
| 10 | Globus Medical | 11.70 Bn | 11.11 Bn | 548.17 Mn | 0.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.87% |
| Mar 31, 2026 | 51.52% |
| Dec 31, 2025 | 586.07% |
| Sep 30, 2025 | 152.48% |
| Jun 30, 2025 | 295.48% |
| Mar 31, 2025 | 1,305.44% |
| Dec 31, 2024 | -1.31% |
| Sep 30, 2024 | 2,149.78% |
| Jun 30, 2024 | -36.28% |
| Mar 31, 2024 | -113.61% |
| Dec 31, 2023 | -59.76% |
| Sep 30, 2023 | -95.88% |
| Jun 30, 2023 | 5.86% |
| Mar 31, 2023 | 29.23% |
| Dec 31, 2022 | 137.65% |
| Sep 30, 2022 | 12.88% |
| Jun 30, 2022 | 44.16% |
| Mar 31, 2022 | -14.51% |
| Dec 31, 2021 | -365.20% |
| Sep 30, 2021 | 2.49% |